The Real Cost of Medical Device Registration in Southeast Asia (Updated 2026)

Most cost estimates for medical device registration in Southeast Asia focus on government fees. Government fees are the smallest component of the total cost and the easiest to look up. The actual cost breakdown is: government fees at the bottom, regulatory consultant fees 2–5x higher, and timeline cost — the cost of not generating revenue while you wait — as the largest cost of all. Most companies underweight the last category because it doesn't appear on an invoice.

This is a general guide with ballpark figures. Costs vary significantly by device class, product complexity, whether your technical documentation is in good shape, and the specific consultant you work with. Get specific quotes before budgeting.

Indonesia (BPOM)

Government fees: BPOM registration fees are set by regulation and are relatively modest — for Class B devices, roughly IDR 5–15 million (approximately USD 300–900) per product per application. Class C and D fees are higher but still in the low thousands of dollars range. These fees change periodically and can vary by device type, so verify current rates with your regulatory consultant or directly from BPOM.

Regulatory consultant fees: This is where costs escalate. A competent Indonesia regulatory consultant — either a local consultancy or the regulatory services arm of a distributor — will charge USD 2,000–8,000 per product for a straightforward Class B registration, more for Class C/D. For complex submissions, challenging device types, or cases where there are deficiency responses required, costs can exceed USD 15,000 per product.

Translation costs: BPOM requires documentation in Bahasa Indonesia. Technical translation for a medical device technical file costs USD 1,000–5,000 depending on document volume and complexity.

Timeline cost: BPOM official timelines for Class B are 60 working days; Class C/D are 90 working days. Real-world timelines are longer — 6–18 months is common, and for complex products in high-volume application periods, 24 months is not unheard of. If your product is expected to generate USD 500,000 in Indonesia revenue in its first year of sales, a 12-month delay is a USD 500,000 cost that doesn't appear anywhere in your registration budget.

Realistic total for one Class B product, first registration: USD 5,000–15,000 in direct costs, plus timeline cost at your product's expected revenue rate.

Singapore (HSA)

Singapore is the most straightforward market in the region. HSA is English-language, well-organized, and has clear guidance documentation. Timeline efficiency is significantly better than other ASEAN markets.

Government fees: HSA registration fees are structured by device class and risk level. Class A devices (notification) have minimal fees. Class B fees are in the SGD 700–1,500 range (approximately USD 520–1,120). Class C and D fees are higher, in the SGD 2,000–5,000 range.

Regulatory consultant fees: Many companies manage Singapore registrations with minimal external consultant support because the process is relatively clear and English-language. When consultants are used, fees for Class B products typically run USD 2,000–5,000. Class C/D submissions with comprehensive technical files may cost USD 5,000–15,000 in consultant fees.

Timeline cost: HSA's official timelines are among the most reliable in the region — Class B approval within 90 days is achievable for complete submissions. This is why Singapore is often the first Asian market for companies with new products: you can get to market faster, generate clinical evidence, and use that to support other market registrations.

Realistic total for one Class B product, first registration: USD 3,000–8,000 in direct costs, with meaningfully better timeline certainty than other markets.

Malaysia (MDA)

Malaysia falls between Singapore's efficiency and Indonesia's complexity. English is widely used, the process is organized, but timelines are less reliable than Singapore's.

Government fees: MDA registration fees are set in Malaysian Ringgit. For Class B devices, fees are in the MYR 1,000–3,000 range (approximately USD 220–660). Class C and D fees are higher.

Regulatory consultant fees: Consultant fees for Malaysia are typically USD 2,000–6,000 for Class B products, more for higher-class devices. Malaysia requires an Authorized Representative who takes regulatory responsibility — this entity often charges an annual fee (USD 1,000–5,000) in addition to registration filing fees.

Timeline cost: Official MDA timelines are 30–90 working days by class. In practice, Class C/D timelines can extend to 12–18 months. The Authorized Representative relationship creates an ongoing annual cost that should be budgeted across the registration lifecycle.

Realistic total for one Class B product, first registration: USD 5,000–12,000, plus ongoing AR annual fee of USD 1,000–5,000 per year.

Thailand (FDA-TH)

Thailand has been working to streamline its registration process but remains more complex than Malaysia or Singapore. Thai-language requirements add cost and time.

Government fees: Thai FDA fees are relatively low — for Class II devices, fees are in the THB 10,000–50,000 range (approximately USD 280–1,400). Class III fees are higher.

Regulatory consultant fees: Thailand's Thai-language requirements mean you effectively need a Thailand-specialized consultant for most submissions. Consultant fees for Class II products run USD 3,000–8,000. Class III submissions are more expensive.

Translation costs: Thai-language documentation adds USD 1,500–4,000 per product depending on document volume.

Timeline cost: Thai FDA official timelines are 90–180 days for Class II, longer for Class III. Real-world timelines are often 12–24 months for Class III. The Thai FDA has been improving throughput, but submission volume has also increased, keeping real-world timelines elevated.

Realistic total for one Class II product, first registration: USD 6,000–15,000 in direct costs.

The hidden cost: opportunity foregone

The calculation that almost never appears in registration budget discussions is the opportunity cost of the timeline. If your medical device would generate USD 1 million per year in Indonesia once registered, and registration takes 18 months, that's USD 1.5 million of revenue that didn't happen. That cost is orders of magnitude larger than government fees plus consultant fees combined.

This framing changes how you should think about registration investment. Spending an extra USD 10,000 on an experienced consultant who can navigate BPOM more efficiently and avoid deficiency responses — potentially saving 6 months of review time — has a potential return of USD 500,000 in earlier revenue. That's not a consultant fee; it's an investment with a defined return.

The same logic applies to preparation quality. Technical documentation that's complete, well-organized, and clearly responsive to BPOM's specific requirements goes through faster than documentation that's complete but not organized for the specific regulator. The cost of good technical writing for your dossier is small relative to the timeline impact of a poorly organized submission.

Multi-market strategy and cost amortization

If you're registering in multiple markets simultaneously, some documentation costs are shared. A technical file built to ASEAN AMDD standards can be used as the foundation for Indonesia, Malaysia, and Thailand with market-specific adaptations. Clinical evidence from one market can support applications in others. The marginal cost of the second and third ASEAN markets is lower than the first.

This is the economic argument for registering in multiple markets in parallel rather than sequentially: the fixed preparation costs are the same whether you're filing in one market or three, and spreading those costs across multiple markets improves the return on the documentation investment.

Disclaimer: The numbers in this article are general ballparks based on typical market conditions as of 2026. Individual product complexity, consultant selection, and market conditions will significantly affect actual costs. Get specific quotes from local regulatory consultants in each market before committing to a budget.